Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.

Author: , AdachiJonathan, CranneyAnn, GuyattGordon, PapaioannouAlexandra, RobinsonVivian, SheaBeverley, TugwellPeter, WeaverBruce, WellsGeorge, ZytarukNicole

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To review the effect of risedronate on bone density and fractures in postmenopausal women. DATA SOURCES: We searched MEDLINE from 1966 to the end of 2000 and examined citations of relevant articles and the proceedings of international osteoporosis meetings. STUDY SELECTION: We included ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1210/er.2001-3002

データ提供:米国国立医学図書館(NLM)

Risedronate: A Powerful Weapon in the Fight Against Osteoporosis

In the field of [Osteoporosis Research], finding effective treatments for osteoporosis is paramount. This meta-analysis focuses on the efficacy of risedronate, a bisphosphonate medication, in treating postmenopausal osteoporosis. The researchers review various clinical trials and assess the impact of risedronate on bone density and fracture risk. Their findings demonstrate that risedronate effectively reduces fracture risk and increases bone density in postmenopausal women, highlighting its potential as a valuable treatment option for osteoporosis.

Risedronate: A Promising Treatment for Osteoporosis

This meta-analysis of eight randomized controlled trials reveals that risedronate significantly reduces the risk of both vertebral and nonvertebral fractures in postmenopausal women. The pooled relative risk (RR) for vertebral fractures in women given 2.5 mg or more of risedronate was 0.64 (95% CI 0.54, 0.77). Risedronate also produced positive effects on bone density, with larger increases observed with the 5-mg daily dose. These findings underscore the potential of risedronate as an effective treatment for osteoporosis.

Protecting Your Bones: The Importance of Bone Health

Imagine your bones as a network of sand dunes, providing support and structure. Osteoporosis weakens these dunes, making them more susceptible to collapse. Risedronate, like a sturdy camel, can help strengthen these dunes, reducing the risk of fractures. It's important to prioritize bone health by maintaining a balanced diet, getting regular exercise, and consulting your doctor about potential treatment options.

Dr. Camel's Conclusion

This meta-analysis provides compelling evidence for the efficacy of risedronate in treating postmenopausal osteoporosis. Risedronate has emerged as a powerful tool in the fight against osteoporosis, helping to strengthen bones and reduce fracture risk. Just as a camel's hump provides nourishment for the journey through the desert, risedronate can help nourish our bones, ensuring their strength and resilience.

Date :
  1. Date Completed 2003-02-07
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

12202466

DOI: Digital Object Identifier

10.1210/er.2001-3002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.